Paris, France

André Choulika

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 2.5

ph-index = 6

Forward Citations = 255(Granted Patents)


Company Filing History:


Years Active: 2007-2024

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Journey of André Choulika

Introduction

André Choulika is a distinguished inventor based in Paris, France, known for his significant contributions to the field of immunotherapy. With a remarkable portfolio, he holds a total of 10 patents, showcasing his innovative approaches to medical solutions that harness the power of T cells in combatting diseases.

Latest Patents

Among his latest contributions, Choulika has developed remarkable methods for engineering T cells for immunotherapy by utilizing the RNA-guided Cas nuclease system. This groundbreaking invention focuses on methods to create genetically engineered, non-alloreactive T-cells designed specifically for immunotherapeutic applications. By employing RNA-guided endonucleases, particularly the Cas9/CRISPR system, his techniques allow for the precise targeting of key genes in T-cells. The engineered T-cells are crafted to express chimeric antigen receptors (CAR), thereby redirecting their immune activity to effectively target malignant or infected cells. This invention paves the way for innovative, standardized, and affordable adoptive immunotherapy strategies aimed at treating cancer and viral infections.

Career Highlights

Choulika has played a pivotal role in advancing cutting-edge biotechnologies through his work at notable companies such as Cellectis and Children's Medical Center Corporation. His innovative spirit has significantly impacted the landscape of immunotherapy, affirming his reputation as a forward-thinking inventor.

Collaborations

Throughout his career, Choulika has collaborated with esteemed professionals in the field, including Philippe Duchateau and Laurent Poirot. These partnerships have further enhanced his ability to contribute effectively to the advancements in biotechnology and immunotherapy.

Conclusion

André Choulika's journey as an inventor reflects his dedication to improving health outcomes through innovative technologies. His patents and collaborative efforts are testament to the transformative potential of engineering T cells for immunotherapy. As he continues to push the boundaries of science, Choulika remains an influential figure in the quest for groundbreaking medical innovations.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…